AzTrials
AzTrials

Critically IllCORRINCT01862588

Renal Resistive Index and Cardiac Output Changes During Resuscitation Predict the Occurrence of Acute Kidney Injury in Septic Shock Patients

An observational study of Critically Ill and Acute Kidney Injury, run by Zhongda Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Record the renal resistive index and hemodynamic parameters ( record the cardiac output and stroke volume if the patient's next to kin agree to undertake a PiCCO monitoring ) before and after resuscitation for severe sepsis or septic shock patients, to determine whether the changes of resistive index or hemodynamic… Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Critically Ill, Acute Kidney Injury, Septic Shock
How many people
40 participants
Where
1 siteChina
Study dates
Jan 2013to Jan 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Critical ill patients diagnosed with septic shock who required a fluid resuscitation.

Who may be able to join

  • ≥18 years, Sex unlimited
  • Arriving ICU in 6 hours and diagnosed with severe sepsis or septic shock
  • Physician in charge decide that an aggressive fluid resuscitation was in order

Who cannot join

  • Pregnancy, Age <18 years
  • Ongoing recovery from AKI
  • Known end-stage renal disease or chronic kidney disease(glomerular filtration rate <30mL/min/1.73m2)
  • Known other causes of shock morbidly
  • conditions known to modify RRI, such as renal-artery stenosis, intra-abdominal hypertension(>35cmH2O)

Trial locations and contacts

1 site in 1 country.

Jingchao Luo, MD contact

0086-13605172811

sucapter@163.com

China1 site, 1 recruiting
  • Affiliated Zhongda Hospital of Southeast University

    Nanjing, Jiangsu, 210009

    Xiaohua Qiu, MD, 0086-025 83262553, xiaohua0917@163.com

    Jingchao Luo, MD, 0086-13605172811, sucapter@163.com

    Recruiting

Other trials in China

About this study

Official title: Clinical Study of Renal Resistive Index and Hemodynamic Parameters Changes Caused by Fluid Resuscitation to Predict the Occurrence of Acute Kidney Injury in Septic Shock Patients

Record the renal resistive index and hemodynamic parameters ( record the cardiac output and stroke volume if the patient's next to kin agree to undertake a PiCCO monitoring ) before and after resuscitation for severe sepsis or septic shock patients, to determine whether the changes of resistive index or hemodynamic parameters, especially the cardiac output can be a better parameter to predict AKI

Read the detailed description
  • Purpose: To examine whether the resuscitation-induced changes of renal resistive index or hemodynamic parameters has the superiority as a valid tool to evaluate the renal perfusion improvement and whether the changes can better predict AKI occurrence in severe sepsis or septic shock patients.
  • Methods: Measure the renal resistive index and take record of hemodynamic parameters (use a PiCCO monitoring to measure cardiac output if the patient's next to kin agree to undertake such a catheter ) before and after successful resuscitation for severe sepsis or septic shock patients, followup to determine the occurrence of AKI and mortality.
  • Hypothesis: The changes of resistive index or cardiac output during shock resuscitation may be a better parameter to evaluate renal perfusion and predict AKI, and may have a better value to guide renal protective therapy in septic shock.
Keywords
septic shock, acute kidney injury, renal resistive index
Medical subject headings
Critical Illness, Acute Kidney Injury, Shock, Septic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 7 days AKI occurrence

    Follow up to determine the occurrence of AKI in 7 days after inclusion.

    Measured: 7 days

Secondary outcomes (1)
  1. eGFR

    eGFR when enrolled and 6 hours after enrollment.The 2012 SSC guideline for severe sepsis and septic shock recommend to achieve some six-hour resuscitation goals.So we collect 5ml blood and 2 hrs urine when enrolled(at this time, initiate large amount of fluid resuscitation,which is so called "before resuscitation"). At 6hrs after enrolled,collect another 5ml blood and 2 hrs urine.Glomerular filtration rate (GFR) describes the flow rate of filtered fluid through the kidney. eGFR is Creatinine-based approximations of GFR. We project to use the "Urine Creatinine concentration×Urine Flow Rate/Plasma Creatinine Concentration" formula to calculate the eGFR (collected two hours urine, and examine the plasma and urine creatinine in the middle of the two hours). The lowest plasma creatinine value in the 3 months preceding inclusion was taken as the baseline value, therefore use the value to calculate baseline eGFR by CKD-EPI formula.

    Measured: until 6 hours after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2013 (estimated)
  2. Study startJan 2013
  3. Primary completionJan 2014 (estimated)
  4. Study completionJan 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01862588
Sponsor's protocol ID
201314159
Acronym
CORRI
Status last verified
Jan 2014
First submitted
13 May 2013
Last updated
15 Jan 2014
Results posted
No
Data monitoring committee
No

Publications

  • Luo JC, Qiu XH, Pan C, Xie JF, Yu T, Liu L, Yang Y, Qiu HB. Increased cardiac index attenuates septic acute kidney injury: a prospective observational study. BMC Anesthesiol. 2015 Mar 1;15:22. doi: 10.1186/s12871-015-0005-0. eCollection 2015.

    PubMed 25745357

Questions about this trial

What is this clinical trial studying?

An observational study of Critically Ill and Acute Kidney Injury, run by Zhongda Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Jan 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Xiaohua Qiu, MD (0086-025-83262553, xiaohua0917@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

7 days AKI occurrence (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01862588, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in